 |
Market Cap | 82.02M | EPS (ttm) | -1.94 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | -13.21% |
P/S | 0.07 | EPS next 5Y | - |
P/B | 0.55 | EPS Q/Q | 73.39% |
Dividend | - | Sales Q/Q | -18.75% |
Insider Own | 12.26% | Inst Own | 50.65% |
Insider Trans | 3.98% | Inst Trans | 32.32% |
Short Float | 4.46% | Earnings | Mar 12/a |
Analyst Recom | 4.00 | Target Price | 3.75 |
Avg Volume | 425.24K | 52W Range | 0.75 - 2.61 |
|
|
|
Fossil Group, Inc. engages in the design, marketing and distribution of consumer fashion accessories. The firm operates through the following geographical segments: Americas, Europe, and Asia. Its products include men's and women's fashion watches, jewelry, handbags, small leather goods, belts, sunglasses, shoes, soft accessories and clothing which are sold through department stores, specialty retail locations, specialty watch and jewelry stores, owned retail and factory outlet stores, mass market stores, owned, and affiliate internet sites. The company was founded by Tom Kartsotis in 1984 and is headquartered in Richardson, TX. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Fogliato Franco | CEO | Nov 27 '24 | Buy | 1.49 | 138,825 | 206,849 | 1,750,000 | Nov 29 01:39 PM | Fogliato Franco | CEO | Nov 26 '24 | Buy | 1.37 | 111,175 | 152,310 | 1,611,175 | Nov 29 01:39 PM |
|
|
 |
 |
Market Cap | 5.20B | EPS (ttm) | -2.16 |
P/E | - | EPS this Y | 128.70% |
Forward P/E | 120.37 | EPS next Y | 558.06% |
PEG | - | EPS past 5Y | 7.21% |
P/S | 123.70 | EPS next 5Y | - |
P/B | 25.40 | EPS Q/Q | -127.59% |
Dividend | - | Sales Q/Q | - |
Insider Own | 12.31% | Inst Own | 69.61% |
Insider Trans | -26.82% | Inst Trans | -0.55% |
Short Float | 12.13% | Earnings | Feb 27/b |
Analyst Recom | 1.00 | Target Price | 80.33 |
Avg Volume | 1.40M | 52W Range | 11.39 - 70.40 |
|
|
|
Verona Pharma Plc engages in the development and commercialization of therapeutics for the treatment of respiratory diseases. It focuses on developing inhaled ensifentrine for the maintenance treatment of chronic obstructive pulmonary disease. The company was founded by Michael J. A. Walker and Clive P. Page on February 24, 2005 and is headquartered in London, the United Kingdom. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Rickard Kathleen A. | Chief Medical Officer | Mar 12 '25 | Sale | 8.35 | 79,264 | 661,942 | 2,608,976 | Mar 13 08:15 PM | KATHLEEN RICKARD | Officer | Mar 12 '25 | Proposed Sale | 62.70 | 9,908 | 621,232 | | Mar 12 04:23 PM | EBSWORTH DAVID R | Director | Feb 26 '25 | Option Exercise | 1.30 | 460,000 | 600,060 | 1,400,003 | Feb 28 04:30 PM | ZACCARDELLI DAVID | President and CEO | Dec 05 '24 | Sale | 5.01 | 640,264 | 3,205,226 | 14,367,552 | Dec 06 05:51 PM | ZACCARDELLI DAVID | President and CEO | Dec 06 '24 | Sale | 5.01 | 162,800 | 815,400 | 14,204,752 | Dec 06 05:51 PM |
|
|
 |
 |
Market Cap | 29.31M | EPS (ttm) | -1.51 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | 1.37 | EPS next 5Y | - |
P/B | 0.37 | EPS Q/Q | -168.17% |
Dividend | 9.36% | Sales Q/Q | 124.20% |
Insider Own | 2.27% | Inst Own | 7.11% |
Insider Trans | 35.52% | Inst Trans | 423.27% |
Short Float | 1.61% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 141.49K | 52W Range | 1.05 - 6.07 |
|
|
|
MacKenzie Realty Capital, Inc. engages in investment activities. It includes buying real estate investment trusts and investing real estate securities. The company was founded by Charles Evans Patterson on January 25, 2012 and is headquartered in Moraga, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
DIXON ROBERT E | CEO/President | Mar 14 '25 | Buy | 1.92 | 10,000 | 19,200 | 92,263 | Mar 14 06:59 PM | DIXON ROBERT E | CEO/President | Mar 11 '25 | Buy | 1.92 | 2,263 | 4,338 | 82,263 | Mar 11 04:34 PM | DIXON ROBERT E | CEO/President | Mar 05 '25 | Buy | 1.85 | 40,000 | 73,972 | 80,000 | Mar 05 04:58 PM | Simpson Christine Elizabeth | Chief Portfolio Manager | Mar 05 '25 | Buy | 1.85 | 1,000 | 1,850 | 1,000 | Mar 05 02:15 PM | DIXON ROBERT E | CEO/President | Jan 21 '25 | Buy | 2.56 | 15,000 | 38,400 | 40,000 | Jan 22 12:55 PM |
|
|
|  |
 |
Market Cap | 24.27M | EPS (ttm) | -0.01 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | 69.33 | EPS next 5Y | - |
P/B | 35.65 | EPS Q/Q | -109.80% |
Dividend | - | Sales Q/Q | -55.41% |
Insider Own | 56.72% | Inst Own | 1.06% |
Insider Trans | 0.00% | Inst Trans | 2.55% |
Short Float | 2.74% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 880.50K | 52W Range | 0.54 - 13.00 |
|
|
|
QMMM Holdings Ltd. engages in the provision of digital advertising services. It offers interactive design, animation, art-tech and virtual technologies used in commercial campaigns. It has worked with domestic and international banks, real estate developers, amusement parks, international sports apparel, footwear brands, luxury cosmetic products, and international brands. The company was founded by Bun Kwai on July 29, 2022 and is headquartered in Hong Kong. |
|
 |
 |
Market Cap | 4.41M | EPS (ttm) | -7.90 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | 14.18% |
P/S | - | EPS next 5Y | - |
P/B | - | EPS Q/Q | -0.05% |
Dividend | - | Sales Q/Q | - |
Insider Own | 25.48% | Inst Own | 3.22% |
Insider Trans | 0.00% | Inst Trans | -18.75% |
Short Float | 4.23% | Earnings | Feb 14/a |
Analyst Recom | 1.00 | Target Price | 40.00 |
Avg Volume | 91.70K | 52W Range | 0.55 - 34.80 |
|
|
|
Know Labs, Inc. engages in the development, marketing, and sale of a photonics technology. It offers its product under the ChromaID brand. The firm operates through the following segments: The Development of Bio-RFID and ChromaID Technology, Particle, Inc. Technology, and AI Sales of NFT Products. Know Labs was founded by Ronald Peter Erickson on October 8, 1998 and is headquartered in Seattle, WA. |
|
|  |
 |
Market Cap | 153.63M | EPS (ttm) | -2.81 |
P/E | - | EPS this Y | 306.93% |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | 31.55% |
P/S | 19.35 | EPS next 5Y | - |
P/B | 2.50 | EPS Q/Q | 78.30% |
Dividend | - | Sales Q/Q | 773.84% |
Insider Own | 68.81% | Inst Own | 11.68% |
Insider Trans | 0.74% | Inst Trans | 25.66% |
Short Float | 19.45% | Earnings | Feb 26 |
Analyst Recom | 1.00 | Target Price | 20.00 |
Avg Volume | 347.37K | 52W Range | 4.91 - 16.08 |
|
|
|
Prairie Operating Co. engages in development, exploration, and production of oil, natural gas, and natural gas liquids. It focuses on unconventional oil and natural gas reservoirs located in Colorado focused on the Niobrara and Codell formations. The company is also a crypto company involved in cryptocurrency mining. Prairie Operating was founded by Gary C. Hanna and Edward Kovalik on May 2, 2001 and is headquartered in Houston, TX. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Paul L. Kessler | Investor / Former Affiliate | Dec 09 '24 | Proposed Sale | 8.05 | 199 | 1,603 | | Dec 09 09:15 PM | Bristol Investment Fund, Ltd. | Investor / Former Affiliate | Dec 06 '24 | Proposed Sale | 7.85 | 24,375 | 191,390 | | Dec 06 06:17 PM | Bristol Investment Fund, Ltd. | Investor / Former Affiliate | Dec 05 '24 | Proposed Sale | 8.05 | 6,268 | 50,450 | | Dec 05 07:38 PM | Thoresen Erik | Director | Jun 21 '24 | Sale | 10.76 | 199 | 2,141 | 4,512 | Jun 25 08:28 PM | Thoresen Erik | Director | Jun 24 '24 | Sale | 10.81 | 115 | 1,243 | 4,397 | Jun 25 08:28 PM |
|
|
 |
 |
Market Cap | 10.11M | EPS (ttm) | 0.28 |
P/E | 4.75 | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | 83.41% |
P/S | 0.59 | EPS next 5Y | - |
P/B | 0.67 | EPS Q/Q | 117.27% |
Dividend | - | Sales Q/Q | -8.77% |
Insider Own | 56.07% | Inst Own | 2.77% |
Insider Trans | 0.00% | Inst Trans | -4.89% |
Short Float | 0.13% | Earnings | Dec 19/b |
Analyst Recom | - | Target Price | - |
Avg Volume | 14.66K | 52W Range | 1.11 - 1.85 |
|
|
|
Euro Tech Holdings Co. Ltd. is engaged in the manufacture and distribution of water treatment equipment. It operates through the Trading and Manufacturing, and Engineering segments. The Trading and Manufacturing segment offers laboratory instruments, analyzers, test kits, and power generation equipment. The Engineering segment involves water and waste-water treatment engineering and air pollution control business through Pact-Yixing, the firm's wholly owned subsidiary. The company was founded on September 30, 1996 and is headquartered in Hong Kong. |
|
|  |
 |
Market Cap | 127.53M | EPS (ttm) | -1.03 |
P/E | - | EPS this Y | 125.93% |
Forward P/E | 7.15 | EPS next Y | 121.43% |
PEG | - | EPS past 5Y | -20.02% |
P/S | 0.23 | EPS next 5Y | - |
P/B | 0.39 | EPS Q/Q | -7776.72% |
Dividend | 1.35% | Sales Q/Q | -20.87% |
Insider Own | 7.09% | Inst Own | 72.82% |
Insider Trans | 0.44% | Inst Trans | -2.19% |
Short Float | 3.82% | Earnings | Mar 14/b |
Analyst Recom | 1.00 | Target Price | 14.00 |
Avg Volume | 282.13K | 52W Range | 4.26 - 14.28 |
|
|
|
American Vanguard Corp. is a holding company which engages in the development and marketing of specialty and agricultural products for crop protection and management, turf and ornamentals management, public and animal health. It also acquires and licenses both new and well-established product lines that serve numerous market niches. The company was founded by Herbert A. Kraft and Glenn A. Wintemute in January 1969 and is headquartered in Newport Beach, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Eilers Peter | See Remarks | Dec 13 '24 | Sale | 5.35 | 3,000 | 16,050 | 38,177 | Dec 17 12:21 PM | Eilers Peter | Director | Dec 13 '24 | Proposed Sale | 5.25 | 3,000 | 15,750 | | Dec 13 01:16 PM | Macicek Steven D | Director | Nov 15 '24 | Buy | 5.97 | 12,000 | 71,640 | 31,218 | Nov 18 07:54 PM | ROSENBLOOM KEITH M | Director | Aug 30 '24 | Buy | 5.74 | 104,492 | 599,784 | 1,168,682 | Sep 05 02:20 PM | ROSENBLOOM KEITH M | Director | Sep 03 '24 | Buy | 5.94 | 25,000 | 148,500 | 1,193,682 | Sep 05 02:20 PM |
|
|
 |
 |
Market Cap | 28.08M | EPS (ttm) | - |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | - | EPS Q/Q | - |
Dividend | - | Sales Q/Q | - |
Insider Own | - | Inst Own | 0.07% |
Insider Trans | - | Inst Trans | 287.79% |
Short Float | - | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 66.02K | 52W Range | 1.96 - 4.05 |
|
|
|
OneConstruction Group Ltd. is a holding company, which engages in the procurement and installation of structural steel for construction projects. It is involved in performing site preparatory and preliminary works, developing detailed work schedules and work allocation plans, implementing construction site works, and conducting site safety supervision and quality control. The company was founded in 2021 and is headquartered in Hong Kong. |
|
 |
 |
Market Cap | 16.05M | EPS (ttm) | -3.32 |
P/E | - | EPS this Y | 74.27% |
Forward P/E | 5.59 | EPS next Y | 131.52% |
PEG | - | EPS past 5Y | 29.33% |
P/S | 0.63 | EPS next 5Y | - |
P/B | 0.71 | EPS Q/Q | -163.86% |
Dividend | - | Sales Q/Q | 9.60% |
Insider Own | 12.18% | Inst Own | 2.50% |
Insider Trans | -28.62% | Inst Trans | -70.29% |
Short Float | 8.55% | Earnings | Mar 07/b |
Analyst Recom | 1.00 | Target Price | 9.00 |
Avg Volume | 2.58M | 52W Range | 1.25 - 6.00 |
|
|
|
Lifeward Ltd. is a medical device company, which engages in the design, development and marketing of wearable robotic exoskeletons. The firm's exoskeletons provide hip and knee motion to enable individuals with spinal cord injury (SCI) to stand upright, walk, turn, and climb and descend stairs. Its products include ReWalk Exo-Suit and ReWalk Personal 6.0. The company was founded by Amit Goffer on June 20, 2001 and is headquartered in Marlborough, MA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Lind Global Fund II LP | 10% Owner | Jan 06 '25 | Sale | 3.36 | 381,676 | 1,283,102 | 1,049,430 | Jan 08 05:20 PM | Lind Global Fund II LP | 10% Owner | Jan 07 '25 | Sale | 1.94 | 191,434 | 371,907 | 857,996 | Jan 08 05:20 PM | Richner Randel | Director | Dec 13 '24 | Sale | 1.68 | 4,285 | 7,214 | 0 | Dec 17 04:08 PM | Turk Joseph E Jr | Director | Dec 13 '24 | Buy | 1.69 | 6,000 | 10,140 | 18,516 | Dec 17 08:55 AM | Swinford Michael | Director | Nov 25 '24 | Buy | 2.03 | 21,622 | 43,858 | 65,040 | Nov 27 08:03 AM |
|
|
|